View Clinical Trial (Medical Research Study)

Inegy vs. the Doubling of Atorvastatin in High Risk Patients - NCT00782184-11030(Clinical Trial 249944)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Manhasset
State:  
NY
Zip Code: 11030
Conditions: Hypercholesterolemia
Purpose: Patients currently taking atorvastatin 20 mg will be switched to either atorvastatin 40mg or ezetimibe/simvastatin 10/40. After 6 weeks of treatment, the percent reduction in low-density lipoprotein cholesterol (LDL-C) will be assessed and compared between the two treatment groups.
Study summary:
Criteria: Inclusion Criteria: - Patients who are either statin naive or on approved lipid lowering therapy for 6 weeks prior to study initiation - Patient meets ATP III High Risk criteria Exclusion Criteria: - Females who are pregnant or breastfeeding - Patient consumes more than 14 alcoholic beverages per week - Patient has been treated with an investigational drug within the last 30 days - Patient has congestive heart failure (NYHA Type III or IV) - Patient has congestive heart failure - Patient has had gastric bypass - Patient is newly diagnosed with type 1 or 2 diabetes - Patient is HIV positive - Patient has a history of drug or alcohol abuse within the last 5 years
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: January 20, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.